ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 56 filers reported holding ONCOCYTE CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $117,000 | +185.4% | 29,656 | 0.0% | 0.01% | +250.0% |
| Q4 2018 | $41,000 | -44.6% | 29,656 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $74,000 | +19.4% | 29,656 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $62,000 | -55.1% | 29,656 | 0.0% | 0.00% | -50.0% |
| Q4 2017 | $138,000 | -38.4% | 29,656 | 0.0% | 0.01% | -42.9% |
| Q3 2017 | $224,000 | +45.5% | 29,656 | 0.0% | 0.01% | +40.0% |
| Q2 2017 | $154,000 | -12.5% | 29,656 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $176,000 | -15.8% | 29,656 | 0.0% | 0.01% | -20.0% |
| Q4 2016 | $209,000 | +40.3% | 29,656 | 0.0% | 0.02% | +25.0% |
| Q3 2016 | $149,000 | +101.4% | 29,656 | +43.3% | 0.01% | +100.0% |
| Q2 2016 | $74,000 | – | 20,696 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $25,851,000 | 1.86% |
| Defender Capital, LLC. | 2,562,130 | $4,001,000 | 1.39% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $18,214,000 | 0.59% |
| Penbrook Management LLC | 578,150 | $861,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $492,000 | 0.52% |
| Orbimed Advisors | 3,493,800 | $5,206,000 | 0.08% |
| CALIBER WEALTH MANAGEMENT, LLC | 75,120 | $112,000 | 0.07% |
| Fort Sheridan Advisors LLC | 135,000 | $201,000 | 0.06% |
| AWM Investment Company, Inc. | 241,867 | $360,000 | 0.05% |
| WEALTH EFFECTS LLC | 49,000 | $73,000 | 0.03% |